skip to Main Content
 

New Roles for Avalere Senior Leadership

  • This page as PDF

Summary

Avalere is pleased to announce the promotion of three leaders in its Evidence & Strategy and Market Access practices.

Laura Housman will provide leadership for Avalere’s Evidence & Strategy practice as senior vice president and practice director. As a managing director in the same practice, Laura applied her background in evidence generation, commercialization, and strategy to research and analyze projects spanning the full spectrum of healthcare sectors and stakeholders. Before joining Avalere, Laura held a variety of impactful leadership positions over the past 25 years across the healthcare ecosystem and in academia, including at Novartis, where she led a team in access and health outcomes in support of molecular diagnostics and targeted therapies.

Lance Grady will step into a new role as executive vice president, Life Sciences Strategy & Growth. For the past 3.5 years, Lance has led the Market Access practice, devising commercialization strategies focused on product launch, pricing, value, access, and reimbursement. Lance has over 25 years of experience in the pharmaceutical and healthcare industries, including 12 years at Bristol-Myers Squibb in various leadership roles in US Market Access, Policy, and Commercialization. In this new position, Lance will lead strategy and growth with Life Sciences for Avalere and in connection with broader teams at Fishawack Health.

Omar Hafez will assume leadership of the Avalere US Market Access team as senior vice president and Market Access practice director. Omar was a managing director in the same practice for 3 years, where he advised a range of clients on issues including supply chain, drug pricing, launch strategy, and oncology market analytics and planning. He brings deep expertise in strategy, operations, commercialization, and analytics across core client segments. Prior to joining Avalere, Omar enjoyed a successful career at McKesson, guiding a sizable business and building on his reputation as a leader of high-performing teams and expert in end-to-end strategic market-access consultancy.

For inquiries, please reach out to media@avalere.com.

About Avalere

A healthcare consulting firm for more than 20 years, Avalere partners with leading life sciences companies, health plans, providers, and investors to bring innovative, data-driven solutions to today’s most complex healthcare challenges. Follow us on LinkedIn and Twitter.

Avalere is a part of Fishawack Health, a purposefully built commercialization partner for the biopharmaceutical, medical technology, and wellness industries. Its 1,500+ experts combine their knowledge and expertise across our core disciplines—medical; marketing; digital experience and technology; policy; value, evidence, and access; and consulting—to create the connections that make better health happen. Visit us at www.fishawack.com.

Webinar: Decoding the CY 2025 Advance Notice Join Avalere’s healthcare policy experts as they dissect the CY 2025 Medicare Advantage Advance Notice and discuss the future trajectory of MA in Part D and potential outcomes, headwinds, and tailwinds for health plans. Learn More
Watch the Recording
From beginning to end, our team synergy
produces measurable results. Let's work together.
Back To Top